CURAXON

Manufacturing · Switzerland · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Rtistrasse 12, 08955, Switzerland

Phone Number

+41 795581229

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About CURAXON

CURAXON Ltd. is a biopharmaceutical company dedicated to developing innovative therapies for patients with neurodegenerative diseases and limited treatment options. Founded in 2020 and based in Oetwil an der Limmat, Switzerland, the company focuses on modifying existing compounds to enhance their pharmacokinetic and pharmacodynamic properties, aiming for greater therapeutic efficacy. CURAXON has established a robust pipeline of drug candidates and is committed to improving the quality of life for patients through scientific innovation. The leadership team, including founder Stefan Kolb, brings extensive experience in the pharmaceutical industry, specializing in neurology and rare neurodegenerative disorders.Explore more
Popular SearchesCURAXON LtdSIC Code 28,283NAICS Code 32,325Show more

Is CURAXON your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Top Manufacturing Companies

Frequently Asked Questions Regarding CURAXON

What is CURAXON's official website?
CURAXON's official website is www.curaxon.com
What is CURAXON's Revenue?
CURAXON's revenue is <$5 Million
What is CURAXON's SIC code?
CURAXON's SIC: 28,283
What is CURAXON's NAICS code?
CURAXON's NAICS: 32,325
How many employees does CURAXON have?
CURAXON has 11-50 employees
What industry does CURAXON belong to?
CURAXON is in the industry of: Manufacturing, Pharmaceuticals, Business Services
How do I contact CURAXON?
CURAXON contact info: Phone number: +41 795581229 Website: www.curaxon.com
What does CURAXON do?

CURAXON Ltd. is a biopharmaceutical company dedicated to developing innovative therapies for patients with neurodegenerative diseases and limited treatment options. Founded in 2020 and based in Oetwil an der Limmat, Switzerland, the company focuses on modifying existing compounds to enhance their pharmacokinetic and pharmacodynamic properties, aimi... ng for greater therapeutic efficacy. CURAXON has established a robust pipeline of drug candidates and is committed to improving the quality of life for patients through scientific innovation. The leadership team, including founder Stefan Kolb, brings extensive experience in the pharmaceutical industry, specializing in neurology and rare neurodegenerative disorders.Read More

Is CURAXON a public company?
CURAXON is private company therefore does not currently have an official ticker symbol
See more information about CURAXON

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.